We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+24.56%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$467B
AUM Growth
+$83.7B
Cap. Flow
+$2.63B
Cap. Flow %
0.56%
Top 10 Hldgs %
22.59%
Holding
4,219
New
118
Increased
2,550
Reduced
1,055
Closed
119

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$524M
2
META icon
Meta Platforms (Facebook)
META
+$458M
3
OTIS icon
Otis Worldwide
OTIS
+$345M
4
TMUS icon
T-Mobile US
TMUS
+$307M
5
ABBV icon
AbbVie
ABBV
+$280M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$878M
2
RTN
Raytheon Company
RTN
+$537M
3
BMY icon
Bristol-Myers Squibb
BMY
+$435M
4
AAPL icon
Apple
AAPL
+$389M
5
ACN icon
Accenture
ACN
+$216M

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Healthcare 14.52%
3 Financials 12.98%
4 Consumer Discretionary 10.98%
5 Communication Services 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACB
3551
Aurora Cannabis
ACB
$173M
$271K ﹤0.01%
2,198
-11,145
-84% -$1.27M
HYRE
3552
DELISTED
HyreCar Inc. Common Stock
HYRE
$271K ﹤0.01%
92,727
ACIU icon
3553
AC Immune
ACIU
$223M
$270K ﹤0.01%
40,225
-2,861
-7% -$20.8K
NSCO.WS
3554
DELISTED
Nesco Holdings, Inc. Warrants, exerciseable for Common Stock
NSCO.WS
$270K ﹤0.01%
1,467,509
-201,580
-12% -$31.2K
MACK
3555
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$270K ﹤0.01%
81,147
BSVN icon
3556
Bank7 Corp
BSVN
$479M
$269K ﹤0.01%
24,786
-1,846
-7% -$17.1K
ACOR
3557
DELISTED
Acorda Therapeutics
ACOR
$268K ﹤0.01%
3,041
-2,348
-44% -$248K
BIOR
3558
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$268K ﹤0.01%
+119
New +$324K
BKTI icon
3559
BK Technologies
BKTI
$300M
$267K ﹤0.01%
15,766
KINS icon
3560
Kingstone Companies
KINS
$289M
$267K ﹤0.01%
60,504
SND icon
3561
Smart Sand
SND
$185M
$265K ﹤0.01%
252,623
-124,412
-33% -$118K
MRUS
3562
DELISTED
Merus
MRUS
$264K ﹤0.01%
16,443
ELVT
3563
DELISTED
Elevate Credit, Inc.
ELVT
$262K ﹤0.01%
177,048
-143,058
-45% -$250K
HPR
3564
DELISTED
HighPoint Resources Corporation
HPR
$262K ﹤0.01%
17,786
-13,192
-43% -$191K
IX icon
3565
ORIX
IX
$44B
$260K ﹤0.01%
21,140
-6,255
-23% -$76.9K
LFT
3566
Lument Finance Trust
LFT
$34.6M
$259K ﹤0.01%
97,862
HIMX
3567
Himax Technologies
HIMX
$2.19B
$257K ﹤0.01%
62,287
-3,008
-5% -$9.72K
BXRX
3568
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$256K ﹤0.01%
44
-37
-46% -$178K
WPF.U
3569
DELISTED
Foley Trasimene Acquisition Corp.
WPF.U
$256K ﹤0.01%
+23,990
New +$251K
FUSE.U
3570
DELISTED
Fusion Acquisition Corp. Units, each consisting of one share of Class A common stock, $0.0001 par va
FUSE.U
$255K ﹤0.01%
+25,000
New +$254K
GLOG
3571
DELISTED
GASLOG LTD
GLOG
$255K ﹤0.01%
91,294
-188,513
-67% -$687K
ENIA
3572
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$254K ﹤0.01%
33,959
+15,490
+84% +$120K
SNGX icon
3573
Soligenix
SNGX
$5.54M
$252K ﹤0.01%
499
-14
-3% -$5.77K
IHG icon
3574
InterContinental Hotels
IHG
$23.9B
$251K ﹤0.01%
5,670
-228
-4% -$10.3K
LPCN icon
3575
Lipocine
LPCN
$17.5M
$251K ﹤0.01%
11,752

Similar funds

Geode Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
  • Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
  • Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
  • Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
  • Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
  • Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
  • Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.

Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.